Medtronic ($MDT) is eyeing overseas acquisitions and has roughly $2 billion a year to spend, said Omar Ishrak at the J.P. Morgan Healthcare Conference in San Francisco, Bloomberg notes. However, "[w]e need to have a far more disciplined approach to acquisitions," said Ishrak. "That may be tough, but we'll have to find a way to do it. It's going to be a big hurdle to get any form of dilution from us." News